Oligopeptidases activity in bipolar disorder: Ndel1 and angiotensin I converting enzyme.

[1]  M. Hayashi,et al.  NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness , 2017, Cellular and Molecular Life Sciences.

[2]  A. Muotri,et al.  Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation , 2016, Journal of Cell Science.

[3]  G. Breen,et al.  Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia , 2015, Translational Psychiatry.

[4]  M. Hayashi,et al.  Protein-Protein and Peptide-Protein Interactions of NudE-Like 1 (Ndel1): A Protein Involved in Schizophrenia. , 2015, Current protein & peptide science.

[5]  G. Benítez-King,et al.  Altered Subcellular Distribution of the 75‐kDa DISC1 Isoform, cAMP Accumulation, and Decreased Neuronal Migration in Schizophrenia and Bipolar Disorder: Implications for Neurodevelopment , 2015, CNS neuroscience & therapeutics.

[6]  J. Sato,et al.  ACE I/D genotype-related increase in ACE plasma activity is a better predictor for schizophrenia diagnosis than the genotype alone , 2015, Schizophrenia Research.

[7]  J. Sato,et al.  Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia--a potential biomarker? , 2013, Journal of psychiatric research.

[8]  C. Nemeroff,et al.  The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion , 2012, Schizophrenia Research.

[9]  N. Brandon,et al.  Assessing the role of endooligopeptidase activity of Ndel1 (nuclear-distribution gene E homolog like-1) in neurite outgrowth , 2010, Molecular and Cellular Neuroscience.

[10]  E. Ozkok,et al.  Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives , 2010, Psychiatric genetics.

[11]  L. Trudeau,et al.  Presynaptic action of neurotensin on dopamine release through inhibition of D2 receptor function , 2009, BMC Neuroscience.

[12]  Michael Berk,et al.  Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  M. Berk,et al.  Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder , 2007, Neuroscience Letters.

[14]  N. Hiraiwa,et al.  Complete Loss of Ndel1 Results in Neuronal Migration Defects and Early Embryonic Lethality , 2005, Molecular and Cellular Biology.

[15]  N. Brandon,et al.  Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Nemeroff,et al.  Neurotensin and dopamine interactions. , 2001, Pharmacological reviews.

[17]  E. Paykel,et al.  No association of an insertion/deletion polymorphism in the angiotensin I converting enzyme gene with bipolar or unipolar affective disorders. , 2000, American journal of medical genetics.

[18]  J. Krieger,et al.  Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans , 2000, Neuroscience Letters.

[19]  A. Camargo,et al.  Isolation of brain endopeptidases: influence of size and sequence of substrates structurally related to bradykinin. , 1976, Biochemistry.